BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217125. A total of 57 filers reported holding BIOPLUS ACQUISITION CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $6,000 | – | 42,528 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atalaya Capital Management LP | 125,000 | $7,500 | 0.01% |
| Q Global Advisors, LLC | 195,489 | $11 | 0.01% |
| MMCAP International Inc. SPC | 325,000 | $18,200 | 0.01% |
| PERISCOPE CAPITAL INC. | 867,072 | $48,556 | 0.01% |
| MARSHALL WACE, LLP | 78,611 | $2,543,066 | 0.01% |
| HGC Investment Management Inc. | 200,000 | $11,200 | 0.00% |
| Spartan Fund Management Inc. | 75,000 | $4,200 | 0.00% |
| EHP Funds Inc. | 125,186 | $7,010 | 0.00% |
| COWEN AND COMPANY, LLC | 522,096 | $29,237 | 0.00% |
| Radcliffe Capital Management, L.P. | 200,049 | $13,943 | 0.00% |